Close the left navigation
NTP Logo

Much of the work carried out by DTT is in support of the National Toxicology Program (NTP), an interagency partnership of the Food and Drug Administration, National Institute for Occupational Safety and Health, and NIEHS.

DTT scientists contribute to research published in standalone reports, NIEHS report series, and NTP report and monograph series.

These publications describe the results of environmental health sciences research that aligns with real-world public health needs, as well as the approaches and methodologies used to conduct that research. This work includes innovative toxicology research conducted to better understand the effects of environmental exposures on human health or to evaluate research methods that may improve our ability to identify hazards.

AbstractFull TextReport TitleYear
NIEHS Report 11NIEHS-11 Report (3MB)NIEHS Report on the Toxicity Studies of Nicotine Bitartrate Dihydrate (CASRN 6019-06-3) Administered in Drinking Water to Sprague Dawley Rats and Swiss Mice2024
DTT SpecificationsToxicology SpecificationsSpecifications for the Conduct of Toxicity Studies by the Division of Translational Toxicology at the National Institute of Environmental Health Sciences2023
NIEHS Report 10NIEHS-10 Report (2MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of Perfluorohexanesulfonamide (CASRN 41997-13-1) in Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2023
NIEHS Report 09NIEHS-09 Report (1MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of 2,3-Benzofluorene (CASRN 243-17-4) in Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2023
NIEHS Report 08NIEHS-08 Report (2MB) NIEHS Report on the In Vivo Biological Potency Study of 1,1,2,2-Tetrahydroperfluoro-1-dodecanol (CASRN 865-86-1) in Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2023
NIEHS Report 07NIEHS-07 Report (2MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of 6:1 Fluorotelomer Alcohol (CASRN 375-82-6) in Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2023
NIEHS Report 06NIEHS-06 Full Report (3MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of Tricresyl Phosphate (CASRN 1330-78-5) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2022
NIEHS Report 05NIEHS-05 Full Report (3MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of Isopropylated Phenol Phosphate (CASRN 68937-41-7) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2022
NIEHS Report 04NIEHS-04 Full Report (3MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of Isodecyl Diphenyl Phosphate (CASRN 29761-21-5) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2022
NIEHS Report 03NIEHS-03 Full Report (3MB)NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of tert-Butylphenyl Diphenyl Phosphate (CASRN 56803-37-3) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2022
NIEHS Report 02NIEHS-02 Full Report (3MB) NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of 2-Ethylhexyl Diphenyl Phosphate (CASRN 1241-94-7) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies)2022
NIEHS Report 01NIEHS-01 Full Report (1MB)NIEHS Report on Evaluating Features and Application of Neurodevelopmental Tests in Epidemiological Studies2022
AIDS-09AIDS-09 Full Report (5MB)NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-deoxythymidine (AZT) and Clarithromycin Combinations (CASRNs 30516-87-1 and 81103-11-9) Administered by Gavage to Swiss (CD-1®) Mice2003
AIDS-08AIDS-08 Full Report (2MB)NIEHS Technical Report on the 13-Week Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Isoniazid Combinations (CASRNs 30516-87-1 and 54-85-3) Administered by Gavage to B6C3F1 Mice2002
AIDS-07AIDS-07 Full Report (4MB)NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Pyrazinamide Combinations (CASRNs 30516-87-1 and 98-96-4) Administered by Gavage to Swiss (CD-1®) Mice2002
AIDS-06AIDS-06 Full Report (5MB)NIEHS Technical Report on the Subchronic Toxicity Study of 3'-Azido-3'-dioxythymidine (AZT) and Rifampicin Combinations (CASRNs 30516-87-1 and 13292-46-1) Administered by Gavage to B6C3F1 Mice2001
AIDS-05AIDS-05 Full Report (2MB)NIEHS Technical Report on the Subchronic Toxicity Study of 3'-Azido-3'-dioxythymidine (AZT) and Pyrazinamide Combinations (CASRNs 30516-87-1 and 98-96-4) Administered by Gavage to B6C3F1 Mice1999
AIDS-04AIDS-04 Full Report (6MB)NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3'-Azido-3'-deoxythymidine (AZT) and Rifabutin Combinations (CASRNs 30516-87-1 and 72559-06-9) Administered by Gavage to Swiss (CD-1®) Mice2000
AIDS-03AIDS-03 Full Report (2MB)NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-dioxythymidine (AZT) and Isoniazid Combinations (CASRNs 30516-87-1 and 54-85-3) Administered by Gavage to Swiss (CD-1®) Mice1999
AIDS-02AIDS-02 Full Report (5MB)NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of 3'-Azido-3'-dioxythymidine (AZT), Trimethoprim (TMP)/ Sulfamethoxazole (SMX), and Folinic Acid Combinations Administered by Gavage to Swiss (CD-1®) Mice1998
AIDS-01AIDS-01 Full Report (888KB)NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Studies of Pyrazinamide (CASRN 98-96-4) Administered by Gavage to Swiss (CD-1®) Mice1997